Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization.
about
Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacinDelafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyInvestigational antimicrobial agents of 2013.Delafloxacin: design, development and potential place in therapyComparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.Delafloxacin for the treatment of respiratory and skin infections.A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.Pipeline of Known Chemical Classes of Antibiotics.New antibiotic agents in the pipeline and how they can help overcome microbial resistance.In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance.In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.New antibiotics for bad bugs: where are we?Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Development of novel antibacterial drugs to combat multiple resistant organisms.In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure InfectionsNew treatment options for lower respiratory tract infections.In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin.A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study.Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties.
P2860
Q26746616-6A4DA1BA-F449-4CD4-B2CB-E0F02546F1C3Q26824268-36323ED1-FF54-460F-A2AD-BA7373B54B03Q34375204-256B35C6-ED83-4EB7-A2BA-B3AB611D8434Q34554381-893E02B3-8E5F-4DDF-8EC8-CB7BBEFDD77DQ34596619-92558E9E-F41B-4AAF-AF80-32AADBCDAD15Q34667588-048F8190-1152-478D-88F8-EBC16B240F25Q35607841-112A5C94-94CE-4544-B85F-7FFDD3D8EDF2Q36683409-8BC2256A-005E-4E8C-A38D-8E4301DD078BQ36845895-6BEC3773-5C09-45B0-81BC-1F19A4CCF4B8Q36887890-C7903DCA-07C4-45D2-A0D0-9FD9A3C75648Q37120092-B1DBA93E-F77C-4B81-80D5-9902E55497E2Q38132217-440683EC-D4AE-4BC1-AACC-CD031B580F17Q38233471-B0538A63-1AAD-4DC1-B16A-7B7165ED3C0EQ38350301-18D7C5A3-42DC-4127-B7FC-E913A6459C4CQ38375319-86762A6E-E6B6-48CB-9EF4-B942C924DECCQ40111519-598396CF-6D7D-40E1-BDB6-E3CA5BD9FB58Q40342746-6B729ED7-9F5D-4F2C-84CE-261B88F24C53Q41989976-D49912AD-FD07-4527-BFDD-68AA12A99347Q47736241-FDC5284F-54EE-44C6-BBAD-E42E045CDBC4Q52579373-2EB20F65-E839-4DA7-819D-E37DF2EBB02EQ54259788-71C1F4F5-25FC-41CE-8C83-B388A0137FC7Q55252138-E6760AE9-5A64-492E-80D8-CFD8652C2E9E
P2860
Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Activity of delafloxacin again ...... election and characterization.
@en
Activity of delafloxacin again ...... election and characterization.
@nl
type
label
Activity of delafloxacin again ...... election and characterization.
@en
Activity of delafloxacin again ...... election and characterization.
@nl
prefLabel
Activity of delafloxacin again ...... election and characterization.
@en
Activity of delafloxacin again ...... election and characterization.
@nl
P2093
P2860
P356
P1476
Activity of delafloxacin again ...... election and characterization.
@en
P2093
Cheryl A Tow-Keogh
James M Dalton
Joan M Remy
Joseph A Devito
Timothy S McConnell
P2860
P304
P356
10.1093/JAC/DKS307
P407
P577
2012-08-08T00:00:00Z